Cardiac resynchronization therapy (CRT) has been shown to reduce mortality and heart failure (HF) hospitalization but its effects on the rate of ventricular arrhythmias (VAs) appears to be neutral. We hypothesize that CRT with LV epicardial stimulation is inherently pro-arrhythmic and increases VA rates in the absence of reverse ventricular remodelling while conferring an anti-arrhythmic effect in mechanical responders. 
Introduction
Cardiac resynchronization therapy (CRT) has been shown to reduce mortality in selected patients with heart failure (HF) 1 but whether CRT reduces ventricular arrhythmias (VAs) remains controversial. Several randomized controlled studies have demonstrated that while CRT significantly reduced mortality and progressive HF, it does not appear to reduce overall VAs. 2, 3 In fact, there have been several studies reporting an increase in VAs immediately after CRT implantation. 4, 5 In the RAFT trial, CRT led to a significant reduction in new onset VAs, but a (non-significant) trend to increased VAs among those requiring secondary prevention devices. 3 One possible explanation is that CRT may be inherently pro-arrhythmic, but through its impact on reverse ventricular remodelling, it is able to exert an overall anti-arrhythmic effect and ultimately reduce the VA burden. In support of this hypothesis, a MADIT-RIT sub-study demonstrated that the difference in VA rates between the implantable cardioverter-defibrillator (ICD) only and cardiac resynchronization therapy-defibrillator (CRT-D) groups does not emerge until after 6 months; which approximates the time needed for apparent reverse ventricular remodelling. 6 We conducted a systematic review and meta-analysis to address the hypothesis that CRT is intrinsically pro-arrhythmic but through LV reverse remodelling, it is able to produce a net anti-arrhythmic effect. We therefore predict that CRT-D non-responders will have higher rates of VAs compared with both CRT-D responders and an ICD only group.
Methods

Search strategy
We conducted a search of electronic databases Medline (1948-July 2017) and Embase applying permutations on the search terms CRT, defibrillator, pacemaker, and implantable (Supplementary material online, Table S1 ). The protocol for this systematic review and meta-analysis was registered on PROSPERO (CRD42017064631) with details of the full protocol published in August 2017. Furthermore, the study was conducted and reported in accordance with PRISMA guidelines. 7 For our analysis, we considered retrospective cohort, prospective cohort, and randomized clinical trials for inclusion. Bibliographies of systematic reviews were also hand searched. Eligible studies compared CRT-D mechanical non-responders to either mechanical responders or ICD only groups using discrete left ventricular volumetric values as assessed by any imaging modality. Our chosen primary outcome was the rate of VAs as determined by either device interrogation or appropriate therapy. We excluded non-English language studies. 
Data extraction and analysis
Results
Literature search
Our initial search identified a total of 2579 citations using both Medline and Embase databases. Thirty-one studies were deemed eligible for fulltext review following screening of titles and abstracts. An additional 12 studies were found through hand searching references. A total of 23 studies were used for the final systematic review and meta-analysis ( Figure 1 ).
Study characteristics
Among the 23 included studies, 11 were retrospective cohort, 10 were prospective cohort, and 2 were randomized clinical trials ( Table 1) . All together 8026 patients were included. The sample size ranged from 69 to 1372 subjects with a mean of 349. Follow-up ranged from 6 to 68 months, with a mean of 34 months. Left ventricular volumetric assessments were performed using echocardiography in 21 studies; 19 of which specified that calculations used the biplane method of disks (modified Simpson's rule). One study used echocardiography in 80% of cases and the remainder was an amalgamation of other modalities including ventriculography and MRI. The final study did not specify how left ventricular volumetric assessment was performed. Thirteen studies defined CRT-D responders using left ventricular ejection fraction (LVEF), this included six studies using an improvement threshold of > _35%, one study > _40%, two studies > _45%, one study > _50%, one study used an absolute increase of LVEF by > _5%, and two studies used an increase of LVEF by > _ 10%. The remaining 10 studies used left ventricular end systolic volume (LVESV) to define response; the threshold was a decrease by > _15% in six studies, by > _10% in three studies, and by > _ 25% in another study. The mean time from device implant to the assessment of response was 11 months, with a range of 3-59 months. Only 11 studies used a blanking period, whereby VAs were not counted following device implant and until the time CRT-D response was determined. Most studies only 
Baseline characteristics of study participants
The mean age of participants in the 23 included studies was 65 [standard deviation (SD) 3.0] and females accounted for only 24% (SD 6.1). Primary prevention devices were implanted in 83% (SD 18.2) of participants and 52% (SD 12.0) had ischaemic cardiomyopathy (ICM). The mean LVEF prior to CRT-D or ICD implantation was 24% (SD 2.9) and 67% (SD 12.1) had a left bundle branch block on ECG. Finally, 28% (SD 16.6) had a history of a non-sinus rhythm or atrial fibrillation ( Table 2 ).
Rates of VAs
The outcome of interest in the majority of studies (13/23) was appropriate defibrillator therapy; antitachycardia pacing or shock for sustained VA. These device events were often validated (17/23) by investigators but the assessors were rarely blinded to the ventricular remodelling outcomes (6/23). (Figure 2) . When the same meta-analysis was performed using the 11 studies (N = 3342) with a pre-defined blanking period, being a CRT-D responder was again associated with fewer VAs, RR 0.51 (95% CI 0.39-0.66, P < 0.01) (Figure 3) . The heterogeneity calculated using the I 2 statistic was 52% in the meta-analysis without blanking and 62% with blanking; considered low to moderate. In 5 (N = 3182) of the 23 studies that provided comparison of VA rates between CRT-D responders and an ICD only group, being a CRT-D responder was associated with fewer VAs, RR 0.59 (95% CI 0.50-0.69, P < 0.01) (Figure 4) . Finally, in the four studies (N = 1639) included in the primary meta-analysis, being a CRT-D non-responder was associated with more VAs than an ICD only group, RR 0.76 (95% CI 0.63-0.92, P = 0.004) ( Figure 5 ). The heterogeneity for both analyses is considered low with a calculated I 2 of 0%.
Discussion
This systematic review and meta-analysis studied the effects of CRT on VA beyond the immediate implant period and demonstrated that in the absence of LV reverse remodelling, rates of VA were higher in CRT patients compared with an ICD only group. In contrast, for patients whose left ventricular systolic function improved after implant, there was a reduction of VAs when compared with non-responders and patients with an ICD only. These findings may explain why prior studies that included both CRT-D responders and non-responders have shown either a higher rate of VAs or no difference when compared with an ICD only group. Indeed, one meta-analysis of randomized clinical trials revealed that CRT may be associated with a risk of increased VAs in patients with more advanced HF at baseline. 32 Similarly, in a sub-study of the COMPANION (Comparison of medical therapy, pacing and defibrillation in HF) 33 randomized trial, there was a trend towards higher rates (Resynchronization/defibrillation for ambulatory heart failure trial) studies demonstrated no significant difference in the rates of VAs between CRT-D and ICD only groups. Although our meta-analyses had substantially more moderate than mild HF patients, we suspect that the results are still generalizable across New York Heart Association (NYHA) functional class. Several studies have shown that after adequate follow-up in a CRT-D population, LV reverse remodelling but not HF symptoms is predictive of future VAs in multivariate analysis. 24, 25 In summary, the neutral effect on VAs seen in several CRT randomized trials may be the result of a balance between higher rates in non-responders and lower ones in responders compared with an ICD only group. However, prospective studies are needed to confirm this concept.
Effects of CRTon VAs through reverse remodelling
Several randomized clinical trials have either directly or indirectly demonstrated that VA burden was reduced in CRT responders following reverse ventricular remodelling. The CARE-HF 34 (Cardiac Resynchronization-HF) trial randomized over 800 participants with severe HF symptoms, left ventricular systolic dysfunction, and evidence of dysynchrony to either CRT or standard HF pharmacological therapy. Remarkably, a significant reduction in sudden cardiac death (SCD) in favour of CRT was noted only when the trial was extended out for an additional 8 months for a mean follow-up of approximately 37 months (7.8% vs. 13.4%, P < 0.01). 35 These results are consistent with an early mortality benefit from CRT due to improvement in haemodynamics and a reduction in HF symptoms, with a later reduction in SCD as the delayed effects of left ventricular reverse remodelling become manifest. Sub-studies of both MADIT-CRT remodelling occurs in patients with ICM, the proportion of patients and extent of remodelling are not as substantial as compared with non-ICM (NICM). 13, 38 However, a multivariate analysis from a REVERSE sub-study 2 suggests that while LV reverse remodelling predicts the incidence of VA, the underlying aetiology of the cardiomyopathy does not. Therefore, it may be that there is a threshold of LV reverse remodelling whereby the risk of VA is reduced with no greater benefit conferred with additional remodelling. Nonetheless, data on VA rates between ICM and NICM patients with CRT-D is limited and if patients with ICM derive less LV remodelling benefit, then it is possible the rates of VA could be higher in this group.
One potential physiological mechanism that explains the relationship between VA and reverse remodelling suggests that LV geometry can alter myocardial electrophysiological properties. In human explanted hearts with dilated or ICM, a delayed potassium rectifier current has been shown to be significantly reduced compared with normal hearts and this in turn promotes the prolongation of action potential repolarization. 39, 40 Itoh et al. 20 validates this concept in a cohort of 84 patients treated with CRT by demonstrating that repolarization, as measured by T peak to end, prolongs immediately following implantation but then steadily decreases over a period of 12 months. This decrease in repolarization from the time of implant paralleled both a reduction in LVESV and the rate of VA over time. More importantly, the mean T peak to end was significantly shorter in mechanical CRT responders compared with non-responders.
Potential pro-arrhythmic mechanisms of CRT
Several mechanisms for CRT related pro-arrhythmia have been postulated, including prolongation of repolarization through epicardial pacing, and facilitation of re-entry circuits by initiating activation near or within scar. In a cohort of 64 patients undergoing ventricular tachycardia (VT) ablation, Roque et al. 41 demonstrated that a re-entry circuit was the underlying mechanism among all patients presenting with CRT-associated proarrhythmia. Furthermore, electroanatomical mapping demonstrated that the epicardial lead was located within scar in 80% of CRT-associated proarrhythmia cases and this occurrence was significantly more frequent compared with those without CRT-associated pro-arrhythmia. Animal studies have also shown that compared with endocardial LV pacing, epicardial pacing leads to an increase in action potential duration, overall transmural dispersion of repolarization (TDR) and more R-on-T extrasystoles, occasionally leading to Torsades-de-Pointes. 42, 43 These results were confirmed in humans with several studies having demonstrated that compared with baseline, biventricular, and LV epicardial pacing produce prolongation in the QTc and JT intervals as well as an overall increase in TDR. 5, 43 Although uncommon, there have been several case reports in the literature describing either electrical storm or polymorphic VT shortly following CRT implantation. 4, 44 These dramatic pro-arrhythmic effects of CRT, including electrical storm, often manifest early after implantation of the device. Although our study was primarily interested in the late effects of CRT on VA, we suspect similar mechanisms are implicated; however, further study is needed to establish a causal relationship.
Clinical significance and future direction
This study suggests that the effects of CRT on VA are complex and while CRT is anti-arrhythmic following LV reverse remodelling, it can also be potentially pro-arrhythmic is in it's absence ( Figure 6 ). Special consideration for non-responders is warranted given that they make up approximately 30% of CRT recipients and may be at risk for CRT associated pro-arrhythmia. Promising options worth further study include CRT LV endocardial pacing, repositioning of the LV lead or multi-site LV pacing and switching off CRT pacing entirely. Multi-site pacing has been particularly promising with several studies demonstrating improvements in acute haemodynamics, an increase LV reverse remodelling, and shortening of QTc and JTc intervals compared with conventional biventricular pacing. [45] [46] [47] Moreover, a cohort study by Ogano et al. 48 of 58 patients selected for either biventricular or multi-site LV pacing based on acute haemodynamic response, reported a significantly lower incidence of VA in the latter group with concomitant shortening in repolarization indices over a mean follow-up of 481 days. A similar reduction in VA was seen in a propensity matched cohort study by Providencia et al. 49 with the authors suggesting that wider stimulation of myocardium allows for a more uniform conduction wave front and that this in turn could mitigate the potential for re-entry VT. Higher pacing rates have also been shown to shorten repolarization indices in CRT patients. 50 While this approach is simple, the impact on clinical outcomes, including VA rates, has yet to be validated prospectively. Finally, LV endocardial pacing is a feasible strategy with a clinical response rate similar to biventricular pacing; however, data on LV reverse remodelling and rates of VA is still emerging. 51 
Limitations
All meta-analyses performed in this study were unadjusted and without population level data, we were unable to assess whether baseline characteristics were similar between groups. Even in the randomized trials included, the baseline characteristics may have changed when subgroups are selected out for analysis. Furthermore, only two studies included in our analyses were randomized clinical trials and a sizable proportion of events were from retrospective non-standardized studies. However, meta-analyses of randomized trials exclusively demonstrated similar results when the ICD only group was compared with CRT non-responders and responders (Supplementary material online, Figures S1 and S2) . The definition of CRT-response varied between studies and so did time to assessment of response. However, this is likely due to the fact that there is no consensus definition of mechanical responder in the literature. Also, several studies did not report on ICD settings or lacked sufficient description, and adjudicators of device detected VA were blinded in only 25% of studies. Finally, the patient population studied was predominantly a primary prevention one and the majority had at least moderate HF. Therefore, it is unclear whether these results are generalizable to those with secondary prevention devices and mild HF.
Conclusion
Our study shows that in a HF population with CRT, left ventricular reverse remodelling is associated with a reduction in the rates of VA as compared with non-responders and an ICD only group. Furthermore, our results demonstrate that CRT is associated with higher rates of VA in non-responders as compared with an ICD only group. These findings suggest that CRT with epicardial LV stimulation may be inherently proarrhythmic, but in those patients who derive reverse remodelling benefit, an overall anti-arrhythmic effect is conferred. However, clinical trials addressing this hypothesis are needed to confirm our results and ultimately determine management for a sizable CRT non-responder population given that the net clinical outcome may be harmful in this group.
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